JP2023181322A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023181322A5 JP2023181322A5 JP2023183525A JP2023183525A JP2023181322A5 JP 2023181322 A5 JP2023181322 A5 JP 2023181322A5 JP 2023183525 A JP2023183525 A JP 2023183525A JP 2023183525 A JP2023183525 A JP 2023183525A JP 2023181322 A5 JP2023181322 A5 JP 2023181322A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025138640A JP2025159230A (ja) | 2018-01-30 | 2025-08-22 | 睡眠時無呼吸を治療するための方法および組成物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862623892P | 2018-01-30 | 2018-01-30 | |
| US62/623,892 | 2018-01-30 | ||
| JP2020542075A JP7422666B2 (ja) | 2018-01-30 | 2019-01-30 | 睡眠時無呼吸を治療するための方法および組成物 |
| PCT/US2019/015781 WO2019152475A1 (en) | 2018-01-30 | 2019-01-30 | Methods and compositions for treating sleep apnea |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542075A Division JP7422666B2 (ja) | 2018-01-30 | 2019-01-30 | 睡眠時無呼吸を治療するための方法および組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025138640A Division JP2025159230A (ja) | 2018-01-30 | 2025-08-22 | 睡眠時無呼吸を治療するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023181322A JP2023181322A (ja) | 2023-12-21 |
| JP2023181322A5 true JP2023181322A5 (https=) | 2024-02-06 |
Family
ID=65441079
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542075A Active JP7422666B2 (ja) | 2018-01-30 | 2019-01-30 | 睡眠時無呼吸を治療するための方法および組成物 |
| JP2023183525A Pending JP2023181322A (ja) | 2018-01-30 | 2023-10-25 | 睡眠時無呼吸を治療するための方法および組成物 |
| JP2025138640A Pending JP2025159230A (ja) | 2018-01-30 | 2025-08-22 | 睡眠時無呼吸を治療するための方法および組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542075A Active JP7422666B2 (ja) | 2018-01-30 | 2019-01-30 | 睡眠時無呼吸を治療するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025138640A Pending JP2025159230A (ja) | 2018-01-30 | 2025-08-22 | 睡眠時無呼吸を治療するための方法および組成物 |
Country Status (27)
| Country | Link |
|---|---|
| US (6) | US11911351B2 (https=) |
| EP (2) | EP3746126B1 (https=) |
| JP (3) | JP7422666B2 (https=) |
| KR (2) | KR102874891B1 (https=) |
| CN (2) | CN111670050A (https=) |
| AU (2) | AU2019214891B2 (https=) |
| BR (1) | BR112020015316A2 (https=) |
| CA (1) | CA3089712A1 (https=) |
| DK (1) | DK3746126T3 (https=) |
| EA (1) | EA202091597A1 (https=) |
| ES (1) | ES2991425T3 (https=) |
| FI (1) | FI3746126T3 (https=) |
| HR (1) | HRP20241412T1 (https=) |
| HU (1) | HUE068505T2 (https=) |
| IL (1) | IL276247A (https=) |
| LT (1) | LT3746126T (https=) |
| MA (1) | MA52861B1 (https=) |
| MD (1) | MD3746126T2 (https=) |
| MX (2) | MX2020008086A (https=) |
| PL (1) | PL3746126T3 (https=) |
| PT (1) | PT3746126T (https=) |
| RS (1) | RS66104B1 (https=) |
| SG (1) | SG11202007226UA (https=) |
| SI (1) | SI3746126T1 (https=) |
| SM (1) | SMT202400400T1 (https=) |
| UA (1) | UA129618C2 (https=) |
| WO (1) | WO2019152475A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEAP202416602A (en) * | 2017-04-28 | 2024-10-10 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
| CN118557736A (zh) | 2019-02-08 | 2024-08-30 | 布里格姆妇女医院 | 用于治疗睡眠呼吸暂停的方法和组合物 |
| US20220362221A1 (en) * | 2019-11-04 | 2022-11-17 | Apnimed, Inc. (Delaware) | Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea |
| WO2022069250A1 (en) | 2020-09-30 | 2022-04-07 | Koninklijke Philips N.V. | Methods and systems for performing dose titration |
| AU2022231133A1 (en) * | 2021-03-04 | 2023-09-21 | Apnimed, Inc. (Delaware) | Combination of reboxetine and a muscarinic receptor antagonist (mra) for use in treating sleep apnea |
| WO2022204228A1 (en) * | 2021-03-24 | 2022-09-29 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea |
| EP4334281A1 (en) | 2021-05-04 | 2024-03-13 | Apnimed, Inc. (Delaware) | Solid forms of (r)-oxybutynin d-malate |
| US20240277719A1 (en) * | 2021-06-17 | 2024-08-22 | Apnimed, Inc. (Delaware) | Norepinephrine reuptake inhibitors for treating sleep apnea |
| KR20240124995A (ko) | 2021-12-22 | 2024-08-19 | 바이엘 악티엔게젤샤프트 | 수면 무호흡의 치료를 위한 a2-아드레날린수용체 하위유형 c (알파-2c) 길항제와 노르에피네프린 재흡수 억제제의 조합물 |
| CA3259602A1 (en) | 2021-12-22 | 2023-06-29 | Bayer Aktiengesellschaft | Combination of an .alpha.2-adrenoceptor subtype c (alpha-2c) antagonists with a muscarinic receptor antagonist for the treatment of sleep apnea |
| EP4522149A1 (en) * | 2022-05-13 | 2025-03-19 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea |
| KR20250000641A (ko) * | 2023-06-27 | 2025-01-03 | 주식회사 아스트로젠 | 수면장애 및/또는 수면장애 관련 질환을 예방, 개선 또는 치료하는 방법 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL124473C (https=) | 1960-07-26 | |||
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| DE69636393T2 (de) | 1995-10-24 | 2006-12-07 | Grünenthal GmbH | Montirelin zur verhinderung der schlafapnoe |
| PT1257277E (pt) | 2000-02-24 | 2005-09-30 | Pharmacia & Upjohn Co Llc | Novas combinacoes de farmacos |
| US20020155113A1 (en) | 2001-03-13 | 2002-10-24 | Miyoung Chun | Methods for treating or preventing cardiovascular disorders by modulating metalloprotease function |
| US20030060513A1 (en) | 2001-09-27 | 2003-03-27 | Arneric Stephen P. | Pharmaceutical composition |
| US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
| US20040235925A1 (en) | 2002-12-17 | 2004-11-25 | Pharmacia Corporation | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
| JP2006524708A (ja) | 2003-04-25 | 2006-11-02 | インディヴァス ファーマシューティカルズ，インコーポレーテッド | 塩化トロスピウムの投与により連続睡眠を促進するための方法 |
| PT1696931E (pt) | 2003-12-22 | 2009-06-12 | Acadia Pharm Inc | Análogos diaril[a,d]ciclo-hepteno substituídos com amino utilizados como agonistas muscarínicos e métodos de tratamento de perturbações neuropsiquiátricas |
| US20060039866A1 (en) | 2004-08-20 | 2006-02-23 | Cypress Bioscience, Inc. | Method for treating sleep-related breathing disorders |
| US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| EP1827450A4 (en) | 2004-11-17 | 2009-04-22 | Cypress Bioscience Inc | METHOD FOR REDUCING THE SIDE EFFECTS OF TREATMENT WITH MIRTAZAPINE |
| CN101132777A (zh) | 2004-12-20 | 2008-02-27 | 科利吉姆制药公司 | 用于睡眠障碍的药物组合物 |
| US20080009538A1 (en) | 2005-03-21 | 2008-01-10 | Phil Skolnick | Methods and compositions for the treatment of urinary incontinence |
| CA2603920A1 (en) | 2005-04-15 | 2006-10-26 | The Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
| US20070021927A1 (en) | 2005-07-21 | 2007-01-25 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Selective resonance of chemical structures |
| FR2889811B1 (fr) | 2005-08-19 | 2009-10-09 | Sanofi Aventis Sa | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique. |
| PL2083811T3 (pl) | 2006-11-22 | 2017-05-31 | Clinical Research Associates, Llc | Sposoby leczenia zespołu downa, zespołu łamliwego chromosomu x oraz autyzmu |
| WO2008122019A1 (en) | 2007-04-02 | 2008-10-09 | Cypress Biosciences, Inc. | Improving the tolerability of both mirtazapine and reboxetine by using them in combination |
| EP2142183A2 (en) | 2007-04-09 | 2010-01-13 | Sepracor Inc. | Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders |
| US8415390B2 (en) | 2008-05-30 | 2013-04-09 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
| US9119777B2 (en) | 2008-05-30 | 2015-09-01 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
| US20090048233A1 (en) | 2007-08-16 | 2009-02-19 | Cypress Biosciences, Inc. | Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination |
| AR069875A1 (es) | 2007-12-21 | 2010-02-24 | Eurand Inc | Composiciones de temazepam para tabletas de desintegracion oral y metodo de preparacion |
| US20100204058A1 (en) | 2009-01-28 | 2010-08-12 | Howard Yuan-Hao Chang | Profiling for Determination of Response to Treatment for Inflammatory Disease |
| EP2552205A4 (en) | 2010-04-01 | 2014-01-01 | Theravida Inc | PROCESS FOR INCREASING SLEEP QUALITY |
| JP2014503593A (ja) | 2011-01-28 | 2014-02-13 | ファンタスティック・メディカル・リサーチ・インスティテュート・エルエルシー | 閉塞性睡眠時無呼吸を処置するための方法 |
| JP2012176958A (ja) | 2012-04-20 | 2012-09-13 | Watson Pharmaceuticals Inc | （ｒ）−オキシブチニンおよび（ｒ）−デスエチルオキシブチニンによる平滑筋機能亢進の処置 |
| DK2964185T3 (da) | 2013-03-05 | 2022-02-14 | Requis Pharmaceuticals Inc | Præparater til behandlingen af søvnrelaterede luftvejslidelser |
| US20170304286A1 (en) | 2014-10-24 | 2017-10-26 | Launx Biomedical Co., Ltd. | New indication of paroxetine pharmaceutical composition for treating cancer |
| MX373319B (es) | 2015-04-27 | 2020-06-13 | Arena Pharm Inc | Derivados de hexahidro-[1-4]diazepino[6,7,1-hi]indol-8-carboxamida como agonistas del receptor 5-ht2c y el uso de los mismos en el tratamiento de enfermedades relacionadas con dicho receptor. |
| ES2925951T3 (es) | 2015-07-22 | 2022-10-20 | John Hsu | Composición que comprende un agente terapéutico y un estimulante respiratorio y métodos para su uso |
| WO2017031319A1 (en) | 2015-08-18 | 2017-02-23 | Massachusetts Institute Of Technology | Noradrenergic drug treatment of obstructive sleep apnea |
| GEAP202416602A (en) * | 2017-04-28 | 2024-10-10 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
| AR114350A1 (es) | 2018-01-31 | 2020-08-26 | Res Institute At Nationwide ChildrenS Hospital | Terapia genética para la distrofia muscular de cinturas del tipo 2c |
| CN118557736A (zh) | 2019-02-08 | 2024-08-30 | 布里格姆妇女医院 | 用于治疗睡眠呼吸暂停的方法和组合物 |
-
2019
- 2019-01-30 KR KR1020207024790A patent/KR102874891B1/ko active Active
- 2019-01-30 PL PL19705634.4T patent/PL3746126T3/pl unknown
- 2019-01-30 RS RS20241137A patent/RS66104B1/sr unknown
- 2019-01-30 JP JP2020542075A patent/JP7422666B2/ja active Active
- 2019-01-30 HR HRP20241412TT patent/HRP20241412T1/hr unknown
- 2019-01-30 US US16/965,960 patent/US11911351B2/en active Active
- 2019-01-30 EA EA202091597A patent/EA202091597A1/ru unknown
- 2019-01-30 UA UAA202004819A patent/UA129618C2/uk unknown
- 2019-01-30 HU HUE19705634A patent/HUE068505T2/hu unknown
- 2019-01-30 CA CA3089712A patent/CA3089712A1/en active Pending
- 2019-01-30 MA MA52861A patent/MA52861B1/fr unknown
- 2019-01-30 DK DK19705634.4T patent/DK3746126T3/da active
- 2019-01-30 SI SI201930847T patent/SI3746126T1/sl unknown
- 2019-01-30 KR KR1020257034519A patent/KR20250156197A/ko active Pending
- 2019-01-30 MX MX2020008086A patent/MX2020008086A/es unknown
- 2019-01-30 SM SM20240400T patent/SMT202400400T1/it unknown
- 2019-01-30 BR BR112020015316-8A patent/BR112020015316A2/pt unknown
- 2019-01-30 MD MDE20201230T patent/MD3746126T2/ro unknown
- 2019-01-30 PT PT197056344T patent/PT3746126T/pt unknown
- 2019-01-30 SG SG11202007226UA patent/SG11202007226UA/en unknown
- 2019-01-30 LT LTEPPCT/US2019/015781T patent/LT3746126T/lt unknown
- 2019-01-30 EP EP19705634.4A patent/EP3746126B1/en active Active
- 2019-01-30 ES ES19705634T patent/ES2991425T3/es active Active
- 2019-01-30 CN CN201980010884.XA patent/CN111670050A/zh active Pending
- 2019-01-30 AU AU2019214891A patent/AU2019214891B2/en active Active
- 2019-01-30 CN CN202410467832.8A patent/CN118384147A/zh active Pending
- 2019-01-30 FI FIEP19705634.4T patent/FI3746126T3/fi active
- 2019-01-30 EP EP24183712.9A patent/EP4445951A3/en active Pending
- 2019-01-30 WO PCT/US2019/015781 patent/WO2019152475A1/en not_active Ceased
-
2020
- 2020-07-23 IL IL276247A patent/IL276247A/en unknown
- 2020-07-30 MX MX2024001713A patent/MX2024001713A/es unknown
-
2022
- 2022-08-05 US US17/882,318 patent/US20220378724A1/en not_active Abandoned
-
2023
- 2023-10-25 JP JP2023183525A patent/JP2023181322A/ja active Pending
-
2024
- 2024-01-23 US US18/419,974 patent/US20240156753A1/en not_active Abandoned
- 2024-08-06 US US18/795,245 patent/US20240390299A1/en not_active Abandoned
- 2024-10-25 AU AU2024227631A patent/AU2024227631A1/en active Pending
-
2025
- 2025-02-17 US US19/055,172 patent/US20250186371A1/en not_active Abandoned
- 2025-08-22 JP JP2025138640A patent/JP2025159230A/ja active Pending
- 2025-10-02 US US19/348,331 patent/US20260027070A1/en active Pending